Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 282 results for covid

  1. Risk of systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and COVID-19 who are receiving/have recently received systemic anticancer treatment (SACT) (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of severe COVID-19 illness or death?

    systemic anticancer treatment in people with cancer and COVID-19: Are patients with cancer and...

    Research recommendation
    Published
    21 October 2021

  2. Obstructive sleep apnoea/hypopnoea syndrome and obesity hypoventilation syndrome in over 16s (NG202)

    This guideline covers the diagnosis and management of obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS) and chronic obstructive pulmonary disease with OSAHS (COPD–OSAHS overlap syndrome) in people over 16. It aims to improve recognition, investigation and treatment of these related conditions.

    NICE guideline
    Published
    20 August 2021

    Sections for NG202

  3. What is the efficacy and safety of COVID-specific antiviral drugs in combination with other COVID-specific antiviral drugs or COVID-specific neutralising monoclonal antibodies in people who do not need supplemental oxygen and are within 7 days of symptom onset?

    efficacy and safety of COVID-specific antiviral drugs in combination with other COVID-specific...

    Research recommendation
    Published
    9 March 2022

  4. Lacosamide for adjunctive treatment of primary generalised tonic-clonic seizures in epilepsy [ID1687]

    In development Reference number: GID-TA10664 Expected publication date: TBC

    Technology appraisal guidance
    In development

  5. What is the natural history of post-COVID-19 syndrome?

    of post-COVID-19 syndrome? Any explanatory notes(if applicable) Source guidance details Comes from guidance...

    Research recommendation
    Published
    12 November 2021

  6. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism (NG89)

    This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots, including deep vein thrombosis and pulmonary embolism) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.

    NICE guideline
    Last updated
    13 August 2019
    View recommendations

    Sections for NG89

  7. What risk factors in people who are critically ill and have, or have had, COVID-19 as part of their acute illness are associated with developing COVID-19-associated pulmonary aspergillosis (CAPA)?

    critically ill and have, or have had, COVID-19 as part of their acute illness are associated with developing...

    Research recommendation
    Published
    17 December 2021

  8. Duration of risk of radiotherapy in people with cancer and COVID-19: Are people who have had radiotherapy recently (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of poor outcomes from COVID-19 compared with those who had radiotherapy less recently?

    with cancer and COVID-19: Are people who have had radiotherapy recently (that is, within the 4 weeks preceding a diagnosis...

    Research recommendation
    Published
    21 October 2021

  9. Indoor air quality at home

    In development Reference number: GID-QS10113 Expected publication date: TBC

    Quality standard
    In development

  10. Duration of risk of systemic anticancer treatment in people with cancer and COVID-19: Are people who have had SACT recently (that is, within the 4 weeks preceding a diagnosis of COVID-19) at increased risk of poor outcomes from COVID-19 compared with those who had SACT less recently?

    people with cancer and COVID-19: Are people who have had SACT recently (that is, within the 4 weeks preceding a diagnosis...

    Research recommendation
    Published
    21 October 2021

  11. Perioperative care in adults

    In development Reference number: GID-QS10094 Expected publication date:  01 July 2026

    Quality standard
    In development

  12. What is the efficacy and safety of remdesivir for people who have been vaccinated against COVID-19?

    against COVID-19? Any explanatory notes(if applicable) Suggested PICO (Population, Intervention, Comparator, Outcomes) P:...

    Research recommendation
    Published
    9 March 2022

  13. Impact of COVID-19: What is the medium-to long-term impact of the COVID-19 pandemic on children and young people's social, emotional and mental wellbeing?

    NG223/11 Question Impact of COVID-19: What is the medium-to long-term impact of the COVID-19...

    Research recommendation
    Published
    4 August 2022

  14. What is the clinical effectiveness and safety of vitamin D for treating COVID-19 in children, young people and adults?

    What is the clinical effectiveness and safety of vitamin D for treating COVID-19 in children, young people and adults? Any...

    Research recommendation
    Published
    14 July 2022

  15. What are the possible outcomes for people who are critically ill and have COVID-19-associated pulmonary aspergillosis (CAPA)?

    What are the possible outcomes for people who are critically ill and have COVID-19-associated pulmonary aspergillosis...

    Research recommendation
    Published
    17 December 2021